ribavirin

Generic: ribavirin

Labeler: oceanside pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name ribavirin
Generic Name ribavirin
Labeler oceanside pharmaceuticals
Dosage Form POWDER, FOR SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients

ribavirin 6 g/1

Manufacturer
Oceanside Pharmaceuticals

Identifiers & Regulatory

Product NDC 68682-019
Product ID 68682-019_6b3c6edc-c735-46e0-9b31-fac85dda0992
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018859
Listing Expiration 2026-12-31
Marketing Start 2017-04-14

Pharmacologic Class

Established (EPC)
nucleoside analog antiviral [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68682019
Hyphenated Format 68682-019

Supplemental Identifiers

RxCUI
312818
UNII
49717AWG6K
NUI
N0000175459 N0000175466

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ribavirin (source: ndc)
Generic Name ribavirin (source: ndc)
Application Number NDA018859 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 6 g/1
source: ndc
Packaging
  • 1 VIAL, GLASS in 1 CARTON (68682-019-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS
  • 4 VIAL, GLASS in 1 CARTON (68682-019-06) / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS
source: ndc

Packages (2)

68682-019-01 1 VIAL, GLASS in 1 CARTON (68682-019-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS 68682-019-06 4 VIAL, GLASS in 1 CARTON (68682-019-06) / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS

Ingredients (1)

ribavirin (6 g/1)

Linked Drug Pages (1)

Ribavirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "6b3c6edc-c735-46e0-9b31-fac85dda0992", "openfda": {"nui": ["N0000175459", "N0000175466"], "unii": ["49717AWG6K"], "rxcui": ["312818"], "spl_set_id": ["d74aa4f3-0b7d-480d-b5bf-41ddf808b260"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (68682-019-01)  / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS", "package_ndc": "68682-019-01", "marketing_start_date": "20190827"}, {"sample": false, "description": "4 VIAL, GLASS in 1 CARTON (68682-019-06)  / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS", "package_ndc": "68682-019-06", "marketing_start_date": "20170414"}], "brand_name": "Ribavirin", "product_id": "68682-019_6b3c6edc-c735-46e0-9b31-fac85dda0992", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68682-019", "generic_name": "Ribavirin", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ribavirin", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "6 g/1"}], "application_number": "NDA018859", "marketing_category": "NDA", "marketing_start_date": "20170414", "listing_expiration_date": "20261231"}